Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
GlaxoSmithKline announced that the Food and Drug Administration (FDA) has approved Arnuity Ellipta (fluticasone furoate inhalation powder) for the maintenance treatment of asthma as prophylactic therapy in patients ≥12 years old.
Among infants presenting to an emergency department with mild to moderate bronchiolitis, hospitalization is less likely for those with an artificially elevated pulse oximetry reading.
There is a strong association between severe untreated obstructive sleep apnea (OSA) and resistant elevated blood pressure (BP), despite treatment with an aggressive antihypertensive medication regimen.
Breathlessness - Red flag symptoms
This activity provides in-depth guidance for the pharmacologic and nonpharmacologic treatment of arthritis, and management ...